How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Latest Features
LATEST ARTICLES
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Studies suggest that the majority of pediatric patients with cancer and COVID-19 experience mild disease — rather than severe disease — as a result of infection with the novel virus.
Upfront Radiation May Be a Cost-Effective Strategy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Upfront metastasis-directed therapy may be a viable treatment approach in patients with oligorecurrent disease, particularly those who wish to defer systemic therapy.
New Class of Drug Appears to Extend Survival in Patients With Triple-Refractory Multiple Myeloma
Oncopeptides will seek accelerated approval from the FDA after melflufen demonstrates a manageable safety profile.
Study Points to a Rise in Renal Carcinomas in Children
The increase is thought to be related to environmental factors.
Use of ICIs for Advanced Melanoma in Taiwanese Patients
It was determined that ICIs were less efficacious in Taiwanese patients with melanoma.
Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19
Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.
A Combination of Potential Biomarkers May Help Predict Response to Immunotherapy in mRCC
Combining 2 predictors yielded better results than just using 1.
The Vital Role Genetic Testing Plays in Bladder Cancer Treatments
Recent research suggests cancer patients who have undergone genetic testing for inherited or acquired mutations were more likely to have prolonged overall survival than patients who did not,
Examining Progress and Future Directions in Follicular Lymphoma Treatment
Researchers examine how far follicular lymphoma treatment has come, what limitations still remain, and where the management of the disease is headed.
Prostate Cancer Immunotherapy Alone Is Not Enough
So far, prostate cancer immunotherapy has shown only modest benefits. To greatly improve outcomes, immunotherapy will need to be combined with other treatments, according to the authors of a recent review.
Researchers Hope to Harness AI to Understand, Predict Response to ICIs
Regardless of the efficacy of immune checkpoint inhibition in some settings, many cancers will not respond to treatment with them.
AEs From Ibrutinib in Real-World CLL: More Research Needed
Some tyrosine kinase inhibitors may cause a hyperinflammatory response.
GPS Assay Could Help Guide Treatment Decisions in Unfavorable, Intermediate-Risk Prostate Cancer
Men with GPS scores greater than 40 had a poor disease prognosis after surgery and their disease was likely to behave like that of high-risk patients.
Seven Tips for Managing Health Care Teamwork During a Pandemic
COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
